As of 2024-07-27, the Relative Valuation of Acceleron Pharma Inc (XLRN) is (115.23) USD. This relative valuation is based on P/E multiples. With the latest stock price at 178.75 USD, the upside of Acceleron Pharma Inc based on Relative Valuation is -164.5%.
The range of the Relative Valuation is (108.73) - (116.41) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.8x - 31.4x | 30.8x |
| Forward P/E multiples | 21.8x - 27.6x | 23.8x |
| Fair Price | (108.73) - (116.41) | (115.23) |
| Upside | -160.8% - -165.1% | -164.5% |
| Date | P/E |